Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.
Yun XuHuabing WangTian SongLinlin YinYajun YaoYuzhen WeiHengri CongJiali SunXinghu ZhangDe-Cai TianPublished in: CNS neuroscience & therapeutics (2024)
After PSM analysis, IVMP+PE/IA in acute attack of NMOSD achieved better and continuous improvement in neurological function within 6 months compared with IVMP alone. PE/IA treatment showed a good safety profile.